These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31560491)

  • 41. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.
    da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA
    BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.
    Ratjen F; Hug C; Marigowda G; Tian S; Huang X; Stanojevic S; Milla CE; Robinson PD; Waltz D; Davies JC;
    Lancet Respir Med; 2017 Jul; 5(7):557-567. PubMed ID: 28606620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of viral respiratory infections on pulmonary exacerbations in children with cystic fibrosis.
    Gonzalez-Rosales N; Kasi AS; McCracken CE; Silva GL; Starks M; Stecenko A; Guglani L
    Pediatr Pulmonol; 2023 Mar; 58(3):871-877. PubMed ID: 36479634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
    Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
    Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between early chronic methicillin-susceptible Staphylococcus aureus colonization and lung function in children with cystic fibrosis.
    Sunman B; Yalcin E; Ozsezen B; Tural DA; Buyuksahin HN; Guzelkas I; Emiralioglu N; Dogru D; Özçelik U; Şener B; Kiper N
    Pediatr Pulmonol; 2022 Dec; 57(12):2963-2970. PubMed ID: 35962540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.
    Konstan MW; McKone EF; Moss RB; Marigowda G; Tian S; Waltz D; Huang X; Lubarsky B; Rubin J; Millar SJ; Pasta DJ; Mayer-Hamblett N; Goss CH; Morgan W; Sawicki GS
    Lancet Respir Med; 2017 Feb; 5(2):107-118. PubMed ID: 28011037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients.
    Decaestecker K; Decaestecker E; Castellani C; Jaspers M; Cuppens H; De Boeck K
    Eur Respir J; 2004 May; 23(5):679-84. PubMed ID: 15176679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis.
    De Soyza A; Archer L; Wardle J; Parry G; Dark JH; Gould K; Corris PA
    J Heart Lung Transplant; 2003 Jul; 22(7):764-9. PubMed ID: 12873544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J; Nevitt SJ
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ASSOCIATION OF NUTRITIONAL STATUS WITH LUNG FUNCTION AND MORBIDITY IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: A 36-MONTH COHORT STUDY.
    Hauschild DB; Rosa AF; Ventura JC; Barbosa E; Moreira EAM; Ludwig Neto N; Moreno YMF
    Rev Paul Pediatr; 2018; 36(1):8. PubMed ID: 29412427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D status correlates with the markers of cystic fibrosis-related pulmonary disease.
    Wani WA; Nazir M; Bhat JI; Malik EU; Ahmad QI; Charoo BA; Ali SW
    Pediatr Neonatol; 2019 Apr; 60(2):210-215. PubMed ID: 30093293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.
    Harik NS; Com G; Tang X; Melguizo Castro M; Stemper ME; Carroll JL
    Am J Infect Control; 2016 Apr; 44(4):409-15. PubMed ID: 26684366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.